Apollo Endosurgery

Boston Scientific HQ
MedTech

Boston Scientific snatches up gastro-focused Apollo for $615M

Boston Scientific has laid down a deal to acquire the gastrointestinal device company Apollo Endosurgery, with an offer totaling about $615 million.
Conor Hale Nov 29, 2022 12:51pm
fda

FDA updates warning on intragastric balloons in wake of deaths

Jun 6, 2018 8:55am
orbera weight loss balloon

Apollo bags CE mark for longer-term obesity balloon

Sep 1, 2017 9:58am
FDA

FDA updates gastric balloon warning after 5 deaths

Aug 11, 2017 11:42am
allurion

Allurion bumps up series C to $27M as it revs up for U.S. trial

Jul 11, 2017 9:30am
FDA

Adverse events prompt FDA warning about obesity devices

Feb 10, 2017 4:48am